SYROS PHARMACEUTICALS INC's ticker is and the CUSIP is 87184Q206. A total of 50 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 249,126 | $665,166 | 0.87% |
| Bain Capital Life Sciences Investors, LLC | 2,124,694 | $5,673 | 0.71% |
| CHI Advisors LLC | 767,445 | $2,049,078 | 0.54% |
| Samsara BioCapital, LLC | 881,450 | $2,353,472 | 0.49% |
| Omega Fund Management, LLC | 251,270 | $670,891 | 0.44% |
| Artal Group S.A. | 1,475,744 | $3,940 | 0.23% |
| DAFNA Capital Management LLC | 265,878 | $709,894 | 0.21% |
| Flagship Pioneering Inc. | 993,848 | $2,653,574 | 0.10% |
| Avidity Partners Management LP | 904,630 | $2,415,362 | 0.08% |
| 1492 Capital Management LLC | 21,744 | $58,057 | 0.04% |